ZYNERBA PHARMACEUTICALS INC(NASDAQ:ZYNE) stock News

ZYNE Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: The Motley Fool - Mentions: HRMY

Why Shares of Harmony Bioscience Are Falling on Friday

2 years ago - By: Benzinga - Mentions: HRMY

New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies

2 years ago - By: Zynerba Pharmaceuticals, Inc.

Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions

2 years ago - By: Zynerba Pharmaceuticals, Inc.

Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions

2 years ago - By: Benzinga - Mentions: HRMY

Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals

2 years ago - By: Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023

2 years ago - By: Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023

2 years ago - By: Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium

2 years ago - By: Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium

2 years ago - By: Kahn Swick & Foti, LLC

ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Zynerba Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Harmony

2 years ago - By: Brodsky & Smith LLC - Mentions: SOVO CTG DBTX

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sovos Brands, Inc. (Nasdaq - SOVO), Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc.

2 years ago - By: Brodsky & Smith LLC - Mentions: CD CPRI AVID HRMY ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)

2 years ago - By: InvestorPlace - Mentions: HRMY

Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today?

2 years ago - By: Seeking Alpha - Mentions: HRMY

Zynerba stock surges on buyout deal with Harmony Biosciences

2 years ago - By: Halper Sadeh LLC

ZYNE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Zynerba Pharmaceuticals, Inc. Is Fair to Shareholders

2 years ago - By: Seeking Alpha

Harmony Biosciences to acquire Zynerba for up to $200M cash (NASDAQ:ZYNE)

2 years ago - By: Harmony Biosciences and Zynerba Pharmaceuticals, Inc. - Mentions: HRMY

ZYNERBA PHARMACEUTICALS INC (ZYNE) Stock News

ZYNE Latest News, Press Relases and Analysis

Why Shares of Harmony Bioscience Are Falling on Friday

New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies

Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions

Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions

Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023

Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023

Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium

Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium

ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE

Shareholder Alert: Ademi LLP investigates whether Zynerba Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Harmony

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sovos Brands, Inc. (Nasdaq - SOVO), Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)

Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today?

Zynerba stock surges on buyout deal with Harmony Biosciences

ZYNE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Zynerba Pharmaceuticals, Inc. Is Fair to Shareholders

Harmony Biosciences to acquire Zynerba for up to $200M cash (NASDAQ:ZYNE)

HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.